Virtual Screening and Inhibition of Middle East Respiratory Syndrome Coronavirus Replication by Targeting Papain-like Protease
Infection by the emerging, potentially zoonotic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) presents a severe health hazard to humans and is often fatal. Given the lack of particular medicines against MERS-CoV, drug discovery studies are needed to bridge this knowledge gap. In this study...
Main Authors: | Mahmoud Kandeel, Byoung Kwon Park, Mohamed A. Morsy, Katharigatta N. Venugopala, Kentaro Oh-hashi, Mohammed Al-Nazawi, Hyung-Joo Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2021-11-01
|
Series: | Dr. Sulaiman Al Habib Medical Journal |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125963693/view |
Similar Items
-
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
by: Anastasiia I. Petushkova, et al.
Published: (2020-09-01) -
Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
by: Mohammed Ali Dahhas, et al.
Published: (2023-02-01) -
LAMA PEMBERSIHAN EFISIEN PAPAIN PADA PENGLEPASAN PLAK GIGITIRUAN
by: Siti Sunarintyas
Published: (2015-07-01) -
Myricetin inhibits transmissible gastroenteritis virus replication by targeting papain-like protease deubiquitinating enzyme activity
by: Jiahao Fan, et al.
Published: (2024-07-01) -
A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease
by: Stephanie Patchett, et al.
Published: (2021-09-01)